Supporting our findings, a previous study showed that SHIP1 and SLAMF7 interact in MM cells depending on Src kinase and that elotuzumab triggers the tyrosine phosphorylation of SHIP1 (18). Here, SLAMF7 is linked to Miyoshi myopathy.